Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Neuroscience and Biobehavioral Reviews|July 1, 2024
The iron maiden: Oligodendroglial metabolic dysfunction in multiple sclerosis and mitochondrial signalingRahimeh Emamnejad, Maurice Pagnin, Steven PetratosNeuroscience Letters|October 11, 2021
Enhanced re-myelination in transthyretin null mice following cuprizone mediated demyelinationMaurice Pagnin, Chaitali Dekiwadia, Steven Petratos, et al.Scientific Reports|March 8, 2020
The Role of Transthyretin in Oligodendrocyte DevelopmentBandar Alshehri, Maurice Pagnin, Jae Young Lee, et al.Frontiers in Cellular Neuroscience|June 26, 2023
How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?Zahra Rashidbenam, Ezgi Ozturk, Maurice Pagnin, et al.Frontiers in Endocrinology|August 24, 2019
Thyroid Hormone Distributor Proteins During Development in VertebratesSarah A Rabah, Indra L Gowan, Maurice Pagnin, et al.Frontiers in Neuroendocrinology|January 25, 2021
Role of thyroid hormones in normal and abnormal central nervous system myelination in humans and rodentsMaurice Pagnin, Delphi Kondos-Devcic, Ginevra Chincarini, et al.Frontiers in Pharmacology|September 22, 2022
Thyroid hormone-dependent oligodendroglial cell lineage genomic and non-genomic signaling through integrin receptorsRahimeh Emamnejad, Mary Dass, Michael Mahlis, et al.International Journal of Molecular Sciences|July 14, 2023
The Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion?Olivia Ellen, Sining Ye, Danica Nheu, et al.Cells|December 11, 2022
Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple SclerosisDanica Nheu, Olivia Ellen, Sining Ye, et al.Healthcare (Basel, Switzerland)|June 10, 2023
The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying TherapeuticsKonstantinos Barmpagiannos, Paschalis Theotokis, Steven Petratos, et al.Pageof 2